Intellia Therapeutics (NTLA)
11.21
+0.05 (0.45%)
Upcoming Events
Latest Headlines
Intellia Therapeutics names new chief medical officer
October 13, 2026 7:30 AM - StreetInsider
Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
October 13, 2026 7:30 AM - Globe NewsWire
Form 4 Intellia Therapeutics, For: Oct 02 Filed by: Dube Michael P
October 6, 2026 4:05 PM - SEC Filing
Barclays Starts Intellia Therapeutics (NTLA) at Underweight
October 6, 2026 6:11 AM - StreetInsider
Form 144 Intellia Therapeutics, Filed by: Clark Eliana
October 5, 2026 4:46 PM - SEC Filing
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026 4:01 PM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Intellia Therapeutics (NTLA)
September 9, 2026 7:29 AM - StreetInsider
Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens
September 9, 2026 4:26 AM - StreetInsider
FDA accepts Intellia's lonvo-z application with priority review status
September 8, 2026 8:10 AM - StreetInsider
Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens on HAE Opportunity
September 8, 2026 4:25 AM - StreetInsider
Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens Before ESC Congress
August 25, 2026 4:14 AM - StreetInsider
Form 4 Intellia Therapeutics, For: Aug 20 Filed by: LEONARD JOHN M
August 24, 2026 4:05 PM - SEC Filing
Form 144 Intellia Therapeutics, Filed by: LEONARD JOHN M
August 20, 2026 4:04 PM - SEC Filing
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 4:01 PM - Globe NewsWire
Form SCHEDULE 13G Intellia Therapeutics, Filed by: STATE STREET CORP
August 7, 2026 9:55 AM - SEC Filing
Evercore ISI Upgrades Intellia Therapeutics (NTLA) to Outperform
August 6, 2026 4:17 PM - StreetInsider
Form 10-Q Intellia Therapeutics, For: Jun 30
August 6, 2026 4:08 PM - SEC Filing
Intellia Therapeutics (NTLA) PT Lowered to $49 at Jefferies
August 6, 2026 12:55 PM - StreetInsider
Form 8-K Intellia Therapeutics, For: Aug 06
August 6, 2026 7:45 AM - SEC Filing
Intellia Therapeutics (NTLA) Reports In-Line Q2 EPS
August 6, 2026 7:24 AM - StreetInsider
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
August 6, 2026 7:00 AM - Globe NewsWire
Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates
July 30, 2026 8:00 AM - Globe NewsWire
Full Article List
